Galderma Shares Rise on FDA Nod for Atopic Dermatitis Drug
Shares in Galderma climbed after the company said the U.S. Food and Drug Administration approved its drug Nemluvio for the treatment of patients with atopic dermatitis. Shares in Galderma were 3.2% ...